Erika B. Rosenzweig

Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.

Extracorporeal life support bridge for pulmonary hypertension: A high-volume single-center experience.

A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: Early experience in adolescents and adults.

A rare childhood case of Behcet's disease and chronic thromboembolic pulmonary hypertension.

Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?

SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor?

Cardiac workup and monitoring in hospitalised children with COVID- 19.

Targeted Therapy for Pulmonary Hypertension in Premature Infants.

Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team.

Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City.

Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?

Congenital Heart Disease-Associated Pulmonary Hypertension.

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.

Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.